Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2018-07-04 | 2018-10-12 | 54306 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-02-02 | 2023-04-14 | 183483 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2018-05-16 | 2018-10-12 | 49517 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2021-01-18 | 2021-01-19 | 131886 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-08 | 210659 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2017-07-26 | 2017-10-20 | 17312 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2017-07-26 | 2017-10-20 | 17309 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2017-03-12 | 2017-06-05 | 683 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 224993 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2017-03-12 | 2017-05-31 | 680 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2020-06-04 | 2020-08-17 | 116561 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-02-23 | 2023-04-14 | 185465 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2018-01-22 | 2018-03-15 | 36943 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223055 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2018-04-10 | 2018-10-12 | 45340 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2022-02-04 | 2022-04-15 | 154187 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2018-11-30 | 2019-01-03 | 68239 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2018-11-09 | 2019-01-12 | 66540 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2018-05-15 | 2018-10-12 | 49502 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2022-11-20 | 2023-04-14 | 175324 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |